Cyclopharm

Medical Equipment ManufacturingNew South Wales, Australia11-50 Employees

Cyclopharm is an Australian medical device company listed on the ASX, focused on nuclear medicine. Its flagship product, Technegas, is a lung ventilation imaging agent created by heating technetium-99m in a carbon crucible to form a gas-like inhaled substance used for gamma or SPECT imaging, aiding the assessment of conditions such as pulmonary embolism and related lung diseases. The company targets medical professionals and imaging centers that perform lung ventilation studies, addressing the need for detailed functional ventilation imaging to support diagnosis and management. Based in New South Wales, Cyclopharm operates in the medical equipment manufacturing sector and positions itself around innovations in radiopharmaceutical production, with a new product line under development intended to improve efficiency in radiopharmaceutical production. A recent development includes the anticipated release of Ultralute, a proprietary technology aimed at enhancing production efficiency and healthcare economics in radiopharmaceutical manufacturing.

Sign up for free to view info

Email Format Employee directory